Table 3 Univariate and multivariate analyses of the variables associated with the recurrence of hemoptysis in the patients after BAE treatment
Parameters | Recurrence (n = 69) | Nonrecurrence (n = 43) | Univariate | Multivariate | ||
|---|---|---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |||
Age(years), mean ± SD | 58 ± 11 | 57 ± 13 | 0.98(0.95–1.01) | 0.322 | ||
Sex | ||||||
Female, No. (%) | 43(62.3) | 24(55.8) | 1 | - | ||
Male, No. (%) | 26(37.7) | 19(44.2) | 0.67(0.52–1.39) | 0.095 | ||
Volume of hemoptysis (ml/d), No. (%) | ||||||
< 100 ml | 34(49.3) | 13(30.2) | 1.21(0.50–2.12) | 0.660 | ||
100–300 ml | 23(33.3) | 16(37.2) | 1.37 (0.35–6.45) | 0.530 | ||
> 300 ml | 12(17.4) | 14(32.6) | 2.45 (1.28–6.85) | 0.018* | 0.98(0.89–1.05) | 0.389 |
History of smoking, No. (%) | 24(34.8) | 26(60.5) | 1.32 (0.74–7.28) | 0.435 | ||
Comorbidities, No. (%) | ||||||
Hypertension | 10(14.5) | 6(14.0) | 1.05 (0.65–1.85) | 0.998 | ||
Hepatitis | 2(2.9) | 2(4.7) | 1.00 (0.98–1.02) | 0.895 | ||
Cerebral infarction | 3(4.3) | 2(4.7) | 1.03 (0.38–3.54) | 0.978 | ||
Diabetes mellitus | 5(7.2) | 3(7.0) | 1.00 (0.99–1.20) | 0.435 | ||
The number of lung segments involved | 5(2,8) | 4(2,7) | 1.04 (0.99–1.13) | 0.124 | ||
Bronchial dilatation severity score | 2.0(1.6,2.6) | 1.7(1.1,2.5) | 1.15 (0.85–1.66) | 0.125 | ||
Bronchiectasis type, No. (%) | ||||||
Columnar/varicose | 34(49.3) | 40(93.0) | 1 | - | ||
Cystic | 32(46.4) | 6(14.0) | 2.52 (1.55–5.07) | < 0.001* | 1.52(1.10–6.72) | 0.028* |
The diameter of embosphere microspheres, No. (%) | ||||||
500–750 μm | 45(65.2) | 24(55.8) | 0.52 (0.15–1.38) | 0.170 | ||
700–900 μm | 24(34.8) | 19(44.2) | 0.61 (0.52–1.98) | 0.410 | ||
Presence of SPSs, No. (%) | 37(53.6) | 10(23.3) | 2.47(1.62–6.31) | <0.001* | 1.61(1.12–5.83) | < 0.001* |
The average number of cul print vessels | 3.25 | 2.65 | 2.27(0.52–3.89) | 0.462 | ||
Presence of culprit NBSAs, No. (%) | 22(31.9) | 15(34.9) | 1.81(0.75–4.31) | 0.183 | ||